Milestone Total Current Liabilities from 2010 to 2024
| MLSS Stock | USD 0.72 0.09 11.11% |
Total Current Liabilities | First Reported 1996-06-30 | Previous Quarter 3.6 M | Current Value 3.8 M | Quarterly Volatility 1.7 M |
Check Milestone Scientific financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Milestone Scientific's main balance sheet or income statement drivers, such as Depreciation And Amortization of 142.8 K, Interest Expense of 59.7 K or Selling General Administrative of 8.5 M, as well as many indicators such as Price To Sales Ratio of 8.51, Dividend Yield of 0.0 or PTB Ratio of 4.26. Milestone financial statements analysis is a perfect complement when working with Milestone Scientific Valuation or Volatility modules.
Milestone | Total Current Liabilities |
Latest Milestone Scientific's Total Current Liabilities Growth Pattern
Below is the plot of the Total Current Liabilities of Milestone Scientific over the last few years. Total Current Liabilities is an item on Milestone Scientific balance sheet that include short term debt, accounts payable, accrued salaries payable, payroll taxes payable, accrued liabilities and other debts. Total Current Liabilities of Milestone Scientific are important to investors because some useful performance ratios such as Current Ratio and Quick Ratio require Total Current Liabilities to be accurate. It is the total amount of liabilities that a company is expected to pay within one year, including debts, accounts payable, and other short-term financial obligations. Milestone Scientific's Total Current Liabilities historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Milestone Scientific's overall financial position and show how it may be relating to other accounts over time.
| Total Current Liabilities | 10 Years Trend |
|
Total Current Liabilities |
| Timeline |
Milestone Total Current Liabilities Regression Statistics
| Arithmetic Mean | 3,613,889 | |
| Geometric Mean | 3,278,293 | |
| Coefficient Of Variation | 39.52 | |
| Mean Deviation | 1,081,644 | |
| Median | 3,274,564 | |
| Standard Deviation | 1,428,382 | |
| Sample Variance | 2T | |
| Range | 6M | |
| R-Value | 0.15 | |
| Mean Square Error | 2.1T | |
| R-Squared | 0.02 | |
| Significance | 0.58 | |
| Slope | 49,448 | |
| Total Sum of Squares | 28.6T |
Milestone Total Current Liabilities History
About Milestone Scientific Financial Statements
Milestone Scientific shareholders use historical fundamental indicators, such as Total Current Liabilities, to determine how well the company is positioned to perform in the future. Although Milestone Scientific investors may analyze each financial statement separately, they are all interrelated. The changes in Milestone Scientific's assets and liabilities, for example, are also reflected in the revenues and expenses on on Milestone Scientific's income statement. Understanding these patterns can help investors time the market effectively. Please read more on our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Total Current Liabilities | 3.1 M | 3.1 M |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Milestone Stock Analysis
When running Milestone Scientific's price analysis, check to measure Milestone Scientific's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Milestone Scientific is operating at the current time. Most of Milestone Scientific's value examination focuses on studying past and present price action to predict the probability of Milestone Scientific's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Milestone Scientific's price. Additionally, you may evaluate how the addition of Milestone Scientific to your portfolios can decrease your overall portfolio volatility.